These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21150636)

  • 21. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population.
    Zhang L; Zuo L; Wang F; Wang M; Wang S; Lv J; Liu L; Wang H
    J Am Soc Nephrol; 2006 Sep; 17(9):2617-21. PubMed ID: 16885404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment.
    Siddiqi L; Prakken NH; Velthuis BK; Cramer MJ; Oey PL; Boer P; Bots ML; Blankestijn PJ
    Nephrol Dial Transplant; 2010 Oct; 25(10):3272-7. PubMed ID: 20360012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
    Weiner DE; Tighiouart H; Vlagopoulos PT; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    J Am Soc Nephrol; 2005 Jun; 16(6):1803-10. PubMed ID: 15857925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.
    Garland JS; Holden RM; Groome PA; Lam M; Nolan RL; Morton AR; Pickett W
    Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome.
    Rzeznik D; Przewlocki T; Kablak-Ziembicka A; Kozanecki A; Roslawiecka A; Lach J; Tracz W; Podolec P
    J Vasc Surg; 2011 Mar; 53(3):692-7. PubMed ID: 21129903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure.
    Afshinnia F; Spitalewitz S; Chou SY; Gunsburg DZ; Chadow HL
    Am J Kidney Dis; 2007 Feb; 49(2):227-36. PubMed ID: 17261425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention.
    De Nicola L; Minutolo R; Chiodini P; Zoccali C; Castellino P; Donadio C; Strippoli M; Casino F; Giannattasio M; Petrarulo F; Virgilio M; Laraia E; Di Iorio BR; Savica V; Conte G;
    Kidney Int; 2006 Feb; 69(3):538-45. PubMed ID: 16395261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate.
    Cirillo M; Lanti MP; Menotti A; Laurenzi M; Mancini M; Zanchetti A; De Santo NG
    Arch Intern Med; 2008 Mar; 168(6):617-24. PubMed ID: 18362254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
    Dellegrottaglie S; Sands RL; Gillespie BW; Gnanasekaran G; Zannad F; Sengstock D; Finkelstein F; Kiser M; Eisele G; Hinderliter AL; Levin NW; Cattan V; Saran R; Rajagopalan S
    Nephrol Dial Transplant; 2011 Sep; 26(9):2891-8. PubMed ID: 21562144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild to moderate renal impairment is associated with increased left ventricular mass.
    Greaves K; Chen R; Ge L; Wei M; Tong B; Cai N; Senior R; Hemingway H
    Int J Cardiol; 2008 Mar; 124(3):384-6. PubMed ID: 17399818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malnutrition, renal dysfunction and left ventricular hypertrophy synergistically increase the long-term incidence of cardiovascular events.
    Maruyama K; Nakagawa N; Saito E; Matsuki M; Takehara N; Akasaka K; Sato N; Hasebe N
    Hypertens Res; 2016 Sep; 39(9):633-9. PubMed ID: 27169395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
    Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
    Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of chronic kidney disease and subsequent changes of left ventricular geometry over 4 years in an apparently healthy population aged 60 and older.
    Lee YT; Chiu HC; Su HM; Voon WC; Lin TH; Lai WT; Sheu SH
    Hypertens Res; 2008 May; 31(5):913-20. PubMed ID: 18712047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of echocardiographic parameters on renal outcomes in chronic kidney disease.
    Huang TH; Chiu H; Wu PY; Huang JC; Lin MY; Chen SC; Chang JM
    Ren Fail; 2021 Dec; 43(1):433-444. PubMed ID: 33682579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.